Bustartist Grow Story

Short stature remains the most common reason for referral to a pediatric Endocrinologist and its management remains a challenge. One of the main controversies is the diagnosis of idiopathic short stature and the role of new technologies for genetic investigation of children with inadequate growth.

Bustartist Grow Story 1

Should anthropometrical data be the primary determinant or should biochemical and genetic data be used to improve growth response and safety? Furthermore, what is considered a suboptimal response to growth hormone therapy and how should this be managed?

Bustartist Grow Story 2

Read the latest articles of Growth Hormone & IGF Research at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature

Growth Hormone & IGF Research | Vol 44, Pages 1-42 (February 2019 ...

Bustartist Grow Story 4

Collett-solberg, P. F., Jorge, A. A. de L., Boguszewski, M. C. S., Miller, B. S., Choong, C. S. Y., Cohen, P., et al. (2019). Growth hormone therapy in children; research and practice: a review. Growth hormone & igf research, 44, 20-32. doi:10.1016/j.ghir.2018.12.004.

Growth hormone therapy in children; research and practice - A review ...

Bustartist Grow Story 6

Start Online Investing in Stocks & Direct Mutual Funds with India's No. 1 Stock Broker - Groww. Equity Trading, F&O, Direct Mutual Funds with Zero-commission & 24x7 support.

Groww - Online Demat, Trading and Direct Mutual Fund Investment in India

Bustartist Grow Story 8

Whether you’re saving up for your next adventure or just managing day-to-day expenses, Grow is here to help. From everyday banking to financial literacy education, we make sure you find the right product or service for where you are in life.